Search

Your search keyword '"Reis, Rui M."' showing total 98 results

Search Constraints

Start Over You searched for: Author "Reis, Rui M." Remove constraint Author: "Reis, Rui M." Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
98 results on '"Reis, Rui M."'

Search Results

1. Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

2. Table S1 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

3. Supplementary Table 3 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

4. Supplementary Table 2 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

5. Data from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

6. Supplementary Table 2 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

7. Table S2 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

8. Supplementary Methods from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

9. Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

10. Table S3 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

11. Table S4 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

12. Table S7 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

13. Supplementary Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

14. Table S2 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

15. Supplementary Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

16. Supplementary Table 3 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

17. Supplementary Figure Legends from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

18. Table S1 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

19. Table S5 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

20. Table S5 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

21. Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

22. Supplementary Figure Legends from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

23. Supplementary Table 1 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

24. Supplementary Table 4 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

25. Supplementary Methods from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

26. Supplementary Figures 1 - 13 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

27. Data from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

28. Supplementary Table 4 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

29. Supplementary Figures 1 - 13 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

30. Supplementary Table 1 from Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN

31. Table S4 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

32. Table S7 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

33. Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

34. Table S3 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

35. Supplementary Tables 1 - 6 from Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome

36. Supplementary Data from A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

37. Data from Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome

38. Supplementary Table S3 from A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

40. Supplementary Table S2 from A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

41. Supplementary Table Legends from A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

43. Data from Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome

44. Supplementary Table Legends from A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

46. Supplementary Data from EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines

Catalog

Books, media, physical & digital resources